Marked Increase in Anti-HIV Activity, as Well as Inhibitory Activity against HIV Entry Mediated by CXCR4, Linked to Enhancement of the Binding Ability of Tachyplesin Analogs to CXCR4-Reference-Cited by-同舟云学术

Marked Increase in Anti-HIV Activity, as Well as Inhibitory Activity against HIV Entry Mediated by CXCR4, Linked to Enhancement of the Binding Ability of Tachyplesin Analogs to CXCR4

Published:1999-03-20 Issue:5 Volume:15 Page:419-427
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Xu Younong,Tamamura Hirokazu,Arakaki Rieko,Nakashima Hideki,Zhang Xiaoyan,Fujii Nobutaka,Uchiyama Takashi,Hattori Toshio

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/088922299311169

Reference46 articles.

1. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity

2. Functional Regions of the Envelope Glycoprotein of Human Immunodeficiency Virus Type 1

3. Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells

4. Anti-HIV activity of dextran sulphate as determined under different experimental conditions

5. Triazine Dyes Inhibit HIV-1 Entry by Binding to Envelope Glycoproteins

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological and mutational analyses of CXCR4–antagonist interactions and design of new antagonistic analogs;Bioscience Reports;2023-12

2. Strategies and Progress in CXCR4-Targeted Anti-Human Immunodeficiency Virus (HIV) Therapeutic Development;Clinical Infectious Diseases;2021-02-24

3. The study of targeted blocking SDF-1/CXCR4 signaling pathway with three antagonists on MMPs, type II collagen, and aggrecan levels in articular cartilage of guinea pigs;Journal of Orthopaedic Surgery and Research;2020-05-29

4. Pathogenic Viruses Commonly Present in the Oral Cavity and Relevant Antiviral Compounds Derived from Natural Products;Medicines;2018-11-12

5. Conformational-Restricted Cyclic Peptides;Mid-size Drugs Based on Peptides and Peptidomimetics;2018